Showing results (1-10 of 142) with videos related to
Sort By:
Pageof 15
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 24, 2007
Antisense oligonucleotides in cancer: recent advancesI V Lebedeva, C A SteinProceedings of the National Academy of Sciences of the United States of America|August 30, 2001
A combinatorial approach for selectively inducing programmed cell death in human pancreatic cancer cellsZ Su, I V Lebedeva, R V Gopalkrishnan, et al.Likars'Ka Sprava|July 31, 2002
[Hospitalization for morbidity with respiratory diseases in residents of an industrial city]I V Lebedeva, A V Kudrin, V RomanovKlinicheskaia Laboratornaia Diagnostika|February 12, 1998
[Comprehensive assessment of the work of physicians at clinico-diagnostic laboratories of therapeutic-prophylactic institutions]I V Lebedeva, V S Kudrin, N V BalitskaiaVestnik Otorinolaringologii|October 8, 1999
[Prevalence of ear diseases in children under 7 years of age in Orenburg]I V Lebedeva, Iu P Tolstov, V A Romanov, et al.Molekuliarnaia Biologiia|September 1, 1994
[A new method of covalent immobilization of oligodeoxyribonucleotides on nylon membranes for hybridization with nucleic acids]M G Ivanovskaia, I A Kozlov, I V Lebedeva, et al.Chemistry & Biology|May 1, 1996
Exploiting the potential of antisense: beyond phosphorothioate oligodeoxynucleotidesC A SteinPharmacology & Therapeutics|March 31, 2000
Is irrelevant cleavage the price of antisense efficacy?C A SteinPageof 15